RecruitingPhase 3NCT07037433Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesitySponsor: AmgenMunster, IN · Valparaiso, IN · +138 more sites
RecruitingPhase 3NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesSponsor: Ascletis Pharma (China) Co., LimitedEvansville, IN · Indianapolis, IN · Valparaiso, IN · +81 more sites
RecruitingPhase 2NCT06717698A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseSponsor: Novo Nordisk A/SValparaiso, IN · +17 more sites